-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KRjHNOeH6m1iXn5SQ0Zkjn6ME+TxI8pt4L3Z23BN9A/Dua4+fJg6FdyGIJ6S6TMp zm97NQaUMUezCrxYo6yX1g== 0000732485-03-000020.txt : 20030703 0000732485-03-000020.hdr.sgml : 20030703 20030702175238 ACCESSION NUMBER: 0000732485-03-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030630 FILED AS OF DATE: 20030703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENZYME CORP CENTRAL INDEX KEY: 0000732485 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 061047163 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAN HEEK G JAN CENTRAL INDEX KEY: 0001021040 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-14680 FILM NUMBER: 03773176 BUSINESS ADDRESS: STREET 1: C/O GENZYME CORP STREET 2: ONE KENDALL SQ CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6172527500 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 van47.xml X0101 4 2003-06-30 0 0000732485 GENZYME CORP GENZ 0001021040 VAN HEEK G JAN 0 1 0 0 Executive Vice President Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 4980 0 D 0 D Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 497 0 D 0 I By 401(k) Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 430 0 D 0 I By 401(k) by spouse Genzyme Biosurgery common stock (GZBX) 2003-06-30 4 J 0 558 0 D 0 I By Spouse Genzyme General common stock (GENZ) 2003-06-30 4 J 0 244 0 A 2578 D Genzyme General common stock (GENZ) 2003-06-30 4 J 0 123 0 A 2701 D Genzyme General common stock (GENZ) 2003-06-30 2003-06-30 4 M 0 25000 7.27 A 27701 D Genzyme General common stock (GENZ) 2003-06-30 2003-06-30 4 S 0 25000 43.11 D 2701 D Genzyme General common stock (GENZ) 2003-06-30 4 J 0 24 0 A 806 I By 401(k) Genzyme General common stock (GENZ) 2003-06-30 4 J 0 21 0 A 1664 I By 401(k) by spouse Genzyme General common stock (GENZ) 2003-06-30 4 J 0 27 0 A 3532 I By Spouse Genzyme General common stock (GENZ) 2003-06-30 4 J 0 2 0 A 3534 I By Spouse Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 2181 0 D 0 D Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 5 0 D 0 I By 401(k) Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 5 0 D 0 I By 401(k) by spouse Genzyme Molecular Oncology common stock (GZMO) 2003-06-30 4 J 0 42 0 D 0 I By Spouse Biosurgery NQ stock option (right to buy) 15.12 2003-06-30 4 J 0 1131 0 D 2003-06-30 2003-12-08 Genzyme Biosurgery common stock (GZBX) 1131 0 D Biosurgery NQ stock option (right to buy) 14.10 2003-06-30 4 J 0 452 0 D 1994-12-08 2004-12-08 Genzyme Biosurgery common stock (GZBX) 452 0 D Biosurgery NQ stock option (right to buy) 14.17 2003-06-30 4 J 0 5028 0 D 1994-12-16 2004-12-16 Genzyme Biosurgery common stock (GZBX) 5028 0 D Biosurgery NQ stock option (right to buy) 52.21 2003-06-30 4 J 0 7448 0 D 2005-06-30 2005-12-15 Genzyme Biosurgery common stock (GZBX) 7448 0 D Biosurgery NQ stock option (right to buy) 6.69 2003-06-30 4 J 0 8157 0 D 2001-07-17 2011-02-09 Genzyme Biosurgery common stock (GZBX) 8157 0 D Biosurgery NQ stock option (right to buy) 4.24 2003-06-30 4 J 0 26700 0 D 2002-05-30 2012-05-30 Genzyme Biosurgery common stock (GZBX) 26700 0 D Genzyme General NQ stock option (right to buy) 305.77 2003-06-30 4 J 0 55 0 A 2003-06-30 2003-12-08 Genzyme General common stock (GENZ) 55 55 D Genzyme General NQ stock option (right to buy) 7.27 2003-06-30 2003-06-30 4 M 0 25000 7.27 D 2003-06-30 2003-12-08 Genzyme General common stock (GENZ) 25000 75000 D Genzyme General NQ stock option (right to buy) 285.14 2003-06-30 4 J 0 22 0 A 1994-12-08 2004-12-08 Genzyme General common stock (GENZ) 22 22 D Genzyme General NQ stock option (right to buy) 286.56 2003-06-30 4 J 0 248 0 A 1994-12-16 2004-12-16 Genzyme General common stock (GENZ) 248 248 D Genzyme General NQ stock option (right to buy) 0.00 2003-06-30 4 J 0 368 0 A 2005-06-30 2005-12-15 Genzyme General common stock (GENZ) 368 368 D Genzyme General NQ stock option (right to buy) 124.69 2003-06-30 4 J 0 421 0 A 1997-10-16 2007-10-16 Genzyme General common stock (GENZ) 421 421 D Genzyme General NQ stock option (right to buy) 124.69 2003-06-30 4 J 0 259 0 A 1998-05-28 2008-05-28 Genzyme General common stock (GENZ) 259 259 D Genzyme General NQ stock option (right to buy) 95.84 2003-06-30 4 J 0 1573 0 A 2001-01-25 2009-01-25 Genzyme General common stock (GENZ) 1573 1573 D Genzyme General NQ stock option (right to buy) 226.76 2003-06-30 4 J 0 468 0 A 2000-05-25 2010-05-25 Genzyme General common stock (GENZ) 468 468 D Genzyme General NQ stock option (right to buy) 135.29 2003-06-30 4 J 0 403 0 A 2001-07-17 2011-02-09 Genzyme General common stock (GENZ) 403 403 D Genzyme General NQ stock option (right to buy) 274.32 2003-06-30 4 J 0 505 0 A 2001-05-31 2011-05-31 Genzyme General common stock (GENZ) 505 505 D Genzyme General NQ stock option (right to buy) 85.75 2003-06-30 4 J 0 1320 0 A 2002-05-30 2012-05-30 Genzyme General common stock (GENZ) 1320 1320 D Genzyme General NQ stock option (right to buy) 41.51 2003-06-30 4 J 0 651 0 A 2002-05-30 2012-05-30 Genzyme General common stock (GENZ) 651 651 D Genzyme General NQ stock option (right to buy) 478.27 2003-06-30 4 J 0 634 0 A 2002-03-24 2010-03-24 Genzyme General common stock (GENZ) 634 634 I By Spouse Genzyme General NQ stock option (right to buy) 226.76 2003-06-30 4 J 0 228 0 A 2000-05-25 2010-05-25 Genzyme General common stock (GENZ) 228 228 I By Spouse Molecular Oncology NQ stock option (right to buy) 7.00 2003-06-30 4 J 0 7500 0 D 1997-10-16 2007-10-16 Genzyme Molecular Oncology common stock (GZMO) 7500 0 D Molecular Oncology NQ stock option (right to buy) 7.00 2003-06-30 4 J 0 4625 0 D 1998-05-28 2008-05-28 Genzyme Molecular Oncology common stock (GZMO) 4625 0 D Molecular Oncology NQ stock option (right to buy) 5.38 2003-06-30 4 J 0 28027 0 D 2001-01-25 2009-01-25 Genzyme Molecular Oncology common stock (GZMO) 28027 0 D Molecular Oncology NQ stock option (right to buy) 12.73 2003-06-30 4 J 0 8345 0 D 2000-05-25 2010-05-25 Genzyme Molecular Oncology common stock (GZMO) 8345 0 D Molecular Oncology NQ stock option (right to buy) 15.40 2003-06-30 4 J 0 9000 0 D 2001-05-31 2011-05-31 Genzyme Molecular Oncology common stock (GZMO) 9000 0 D Molecular Oncology NQ stock option (right to buy) 2.33 2003-06-30 4 J 0 11600 0 D 2002-05-30 2012-05-30 Genzyme Molecular Oncology common stock (GZMO) 11600 0 D Molecular Oncology NQ Stock Option (right to buy) 26.85 2003-06-30 4 J 0 11302 0 D 2002-03-24 2010-03-24 Genzyme Molecular Oncology common stock (GZMO) 11302 0 I By Spouse Molecular Oncology NQ stock option (right to buy) 12.73 2003-06-30 4 J 0 4063 0 D 2000-05-25 2010-05-25 Genzyme Molecular Oncology common stock (GZMO) 4063 0 I By Spouse On June 30, 2003 all outstanding shares of Genzyme Biosurgery and Genzyme Molecular stock were exchanged for shares of Genzyme General Stock. Genzyme Biosurgery shareholders received .04914 of a share of Genzyme General stock for each Biosurgery share and Genzyme Molecular Oncology shareholders received .05653 of a share of Genzyme General stock for each Molecular Oncology share. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adpoted by the reporting person on June 16, 2003. On June 30, 2003 in relation to the elimination of Genzyme's tracking stock structure, all stock options of Genzyme Biosurgery and Genzyme Molecular were exchanged for stock options of Genzyme General. The exchange ratio was based on the closing prices of all three stocks on 6/30/03. Genzyme Biosurgery options were exchanged at a rate of .04945 and Genzyme Molecular Oncology options were exchanged at a rate of .05614. Options vest in 1/3 increments on December 8, 1994, March 14, 1996 and March 4, 1997 Options vest in 20% annual increments beginning 12/16/94. Options vest in 25% annual increments on July 17, 2001, 2002, 2003 and 2004. Options vest in 20% annual increments beginning on the original date of grant. These options have a converted exercise price of $1,055.82 per share. The exercise of this stock option resulted in a distribution of 125 shares of Genzyme Biosurgery Division common stock. In connection with the formation of Genzyme Biosurgery in December 2000, shares of Genzyme Tissue Repair were converted at a rate of 0.3352 of a share of Genzyme Biosugery for each share of Genzyme Tissue Repair. The original distribution of Genzyme Tissue Repair was paid on July 22, 1997 to Genzyme General Division stockholders at a rate of 0.015. Options were granted with an exercise price 100% above fair market value, and vest in 1/3 increments on each of Janary 25, 2001, 2002 and 2003. Options vest in 1/3 annual increments beginning on the second year anniversary of the date of grant. Options vest 20% on October 16, 1997 and in 20% annual increments beginning May 16, 1998. By: Susan P. Cogswell, Attorney-in-Fact 2003-07-02 -----END PRIVACY-ENHANCED MESSAGE-----